Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Other Accumulated Expenses (2016 - 2025)

Amdocs (DOX) has disclosed Other Accumulated Expenses for 10 consecutive years, with $159.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 7.83% to $159.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $159.4 million, a 7.83% decrease, with the full-year FY2025 number at $159.4 million, down 7.83% from a year prior.
  • Other Accumulated Expenses was $159.4 million for Q3 2025 at Amdocs, down from $172.9 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $189.8 million in Q3 2022 to a low of $159.4 million in Q3 2025.
  • A 4-year average of $171.0 million and a median of $167.4 million in 2023 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: decreased 14.67% in 2023, then increased 6.75% in 2024.
  • Amdocs' Other Accumulated Expenses stood at $189.8 million in 2022, then dropped by 14.67% to $161.9 million in 2023, then grew by 6.75% to $172.9 million in 2024, then fell by 7.83% to $159.4 million in 2025.
  • Per Business Quant, the three most recent readings for DOX's Other Accumulated Expenses are $159.4 million (Q3 2025), $172.9 million (Q3 2024), and $161.9 million (Q3 2023).